BioCryst Pharmaceuticals Inc (BCRX) — Defensive Interval Ratio
BioCryst Pharmaceuticals Inc (BCRX) has a Defensive Interval Ratio of 329 days as of March 2026. Defensive assets of $176.08 Million (cash $-, short-term investments $66.81 Million, receivables $109.27 Million) cover 329 days of daily cash needs of $535.32K/day. Check BCRX intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
BioCryst Pharmaceuticals Inc Defensive Interval Ratio (1999–2025)
This chart shows how BioCryst Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 27 annual periods from 1999 to 2025. As of March 2026, the ratio stands at 329 days, meaning defensive assets of $176.08 Million can fund 329 days of operations without new revenue. Also explore BCRX year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for BioCryst Pharmaceuticals Inc (1999–2025)
The table below presents the year-by-year Defensive Interval Ratio for BioCryst Pharmaceuticals Inc from 1999 to 2025, covering 27 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see how much is BioCryst Pharmaceuticals Inc worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 543 days | $291.83 Million | $537.17K/day | $- | $185.01 Million | ▼ -129 days |
| 2024 | 672 days | $295.21 Million | $439.41K/day | $- | $216.14 Million | ▼ -144 days |
| 2023 | 816 days | $335.29 Million | $410.93K/day | $- | $278.34 Million | ▲ +227 days |
| 2022 | 589 days | $170.14 Million | $289.08K/day | $- | $119.54 Million | ▲ +474 days |
| 2021 | 115 days | $32.62 Million | $284.16K/day | $- | $3.21 Million | ▼ -13 days |
| 2020 | 127 days | $36.88 Million | $289.46K/day | $- | $28.24 Million | ▼ -47 days |
| 2019 | 175 days | $44.20 Million | $252.97K/day | $- | $22.05 Million | ▼ -256 days |
| 2018 | 431 days | $82.03 Million | $190.35K/day | $- | $77.74 Million | ▲ +88 days |
| 2017 | 343 days | $70.23 Million | $205.03K/day | $- | $64.11 Million | ▲ +65 days |
| 2016 | 277 days | $41.31 Million | $148.93K/day | $- | $32.55 Million | ▲ +114 days |
| 2015 | 164 days | $28.91 Million | $176.58K/day | $- | $22.66 Million | ▼ -12 days |
| 2014 | 175 days | $27.72 Million | $158.05K/day | $- | $18.23 Million | ▼ -279 days |
| 2013 | 455 days | $19.01 Million | $41.80K/day | $- | $16.89 Million | ▲ +46 days |
| 2012 | 408 days | $19.27 Million | $47.19K/day | $- | $14.71 Million | ▼ -568 days |
| 2011 | 976 days | $32.85 Million | $33.65K/day | $- | $25.27 Million | ▲ +51 days |
| 2010 | 926 days | $70.55 Million | $76.22K/day | $- | $40.32 Million | ▲ +322 days |
| 2009 | 603 days | $61.56 Million | $102.06K/day | $- | $27.84 Million | ▼ -489 days |
| 2008 | 1092 days | $51.17 Million | $46.87K/day | $- | $39.19 Million | ▲ +330 days |
| 2007 | 762 days | $58.67 Million | $77.03K/day | $- | $19.54 Million | ▼ -517 days |
| 2006 | 1278 days | $37.60 Million | $29.41K/day | $- | $33.04 Million | ▼ -360 days |
| 2005 | 1639 days | $51.10 Million | $31.18K/day | $- | $21.10 Million | ▼ -207 days |
| 2004 | 1846 days | $14.33 Million | $7.77K/day | $- | $14.33 Million | ▼ -344 days |
| 2003 | 2190 days | $8.09 Million | $3.69K/day | $- | $8.09 Million | ▼ -2255 days |
| 2002 | 4444 days | $10.62 Million | $2.39K/day | $- | $10.62 Million | ▲ +2028 days |
| 2001 | 2416 days | $13.12 Million | $5.43K/day | $- | $13.12 Million | ▲ +983 days |
| 2000 | 1433 days | $16.18 Million | $11.29K/day | $- | $16.18 Million | ▼ -1681 days |
| 1999 | 3113 days | $14.50 Million | $4.66K/day | $- | $14.50 Million | — |